Table 1.

Reported antiviral Activities of bacteria-derived antiviral lectins.

Lectin	Source	Activity (nM)	Cytotoxicity	References
Actinohivin	Longisporum albid K97-0003	HIV (2–110)	No	(Chiba et al, 2001, Chiba et al, 2004, Matoba et al, 2010)
Cyanovirin	Nostoc ellipsosporum	HIV-1 (0.1–160), HIV-2 (2–33), SIV (11–160), HCV (0.6–7.6), HSV-1 (61.82–205), Influenza A and B (0.46–118), Ebola (40–154), & MARV (6–25)	Yes	(Boyd et al, 1997, Gustafson et al, 1997, Balzarini et al, 2006, Witvrouw et al, 2005, Alexandre et al, 2010, Barrientos et al, 2003, O'Keefe et al., 2003, Kachko et al, 2013, Helle et al, 2006, Takebe et al, 2013, Tsai et al, 2004, Tsai et al, 2003)
Microvirin	Microcystis aeruginosa PCC7806	HIV (1.8–167)	Yes	(Shahzad-ul-Hussan et al, 2011, Kehr et al, 2006, Huskens et al, 2010)
MVL	Microcystis viridis NIES-102	HIV & HCV (14–37)	Yes	(Williams et al, 2005, Kachko et al, 2013, Yamaguchi et al, 1999, Bewley et al, 2004)
Scytovirin	Scytonema varium	HIV (0.3–187), Ebola (41), HCV (3.2–96), & MARV (260)	No	(Bokesch et al, 2003, Alexandre et al, 2010, Xiong et al, 2006a, Xiong et al, 2006b, Jensen et al, 2014, Garrison et al, 2014)
OAA	Oscillatoria agardhii NIES-204	HIV (12)	Yes	(Sato et al, 2000, Sato et al., 2007, Koharudin et al, 2012)
PFA	Pseudomonas fluorescens	HIV (15)	Unk	(Koharudin et al., 2012)
MBHA	Myxococcus xanthus	HIV (12)	Unk	(Koharudin et al., 2012)
BOA	Burkholideria oklahomensis EO147	HIV (10–24)	Unk	(Whitley et al., 2013)

Unk - Unknown.